Allison Barraclough

18PUBLICATIONS
108CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

|Feb 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey

|Jun 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.

Eliza A Hawkes, Jodie B Palmer, Richard Khor

|Apr 02, 2025
Establishing best practice in the Australian haematology setting for the use of chimeric antigen receptor T-cell therapy for relapsed and refractory lymphoma.

Michael Dickinson, Nicole O'Leary, Nada Hamad

|Feb 12, 2025
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma.

Cameron S Lewis, Allison Barraclough, Eliza A Hawkes

|Jan 24, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study.

Allison Barraclough, Sze Ting Lee, Melinda Burgess

Pageof 3

Frequent Collaborators

13 joint publications

Eliza Hawkes

5 joint publications

Michael J Dickinson

5 joint publications

Geoffrey Chong

5 joint publications

Chan Y Cheah